Clinical Trials Logo

Clinical Trial Summary

For centuries the term "blood curling" has been used to describe extreme frightening situations. However, the origin of this ancient theory has never been studied and it remains unknown if fear induces the coagulation system.The objective was to explore the effects of acute fear on the coagulation system while sitting still. In a crossover study design healthy subjects will be exposed to a horrifying e.g. scary movie followed by a dull e.g. flat movie which is shown at least 1 week after the first movie on the same day of the week at the same time of the day. Participants will be recruited among students from the Leiden University Medical Center. Blood will be drawn from the cubital vein 10 minutes before the first movie, directly after the first movie. The same will be done 10 minutes before and directly after the second movie. Blood is drawn by using a needle puncture.

Individual markers of coagulation activity will be determined from the blood samples. Pulse rates will be measured and an anxiety/fear score will be collected from each student for both movies.


Clinical Trial Description

Rationale: For centuries the term "blood curling" has been used to describe extreme frightening situations. The term dates back to the medieval physiology, it was believed that the human body contained four chief fluids, blood, phlegm, bile and black bile. It was thought that fear or horror would 'run the blood cold' or 'curdle' (solidify). To date large parts of the complex mechanism of the coagulation cascade have been unravelled and many risk factors for clotting, i.e., thrombosis have been identified. However, the origin of this ancient theory has never been studied and it remains unknown if fear induces the coagulation system.

Objective: To explore the effects of acute fear on the coagulation system while sitting still.

The investigators will compare systemic coagulation markers before and after both movies in each subject: 13 subjects will be exposed to the horrifying movie first, followed by the dull movie (at least 1 week later). Both movies will be shown on the same day of the week, at the same time of the day and will last approximately 90 minutes. One group of 13 will first view the horrifying movie, followed by the dull move the next week (Group I) and 13 subjects will be exposed to the dull movie first, followed by the horrifying movie (Group II). Spacious seats will be used to avoid the effect of immobilisation due to tight cinema seats. Blood is drawn at four time points (TP); (0) before the first movie (baseline), after the first movie (1), before the second movie (2) and after the second movie (3). A needle puncture is used to collect 12 ml of blood at each time point.

Individual markers of coagulation activity will be determined from the blood samples. Pulse rates will be measured and an anxiety/fear score will be collected from each student for both movies. ;


Study Design

Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label


Related Conditions & MeSH terms


NCT number NCT02601053
Study type Interventional
Source Leiden University Medical Center
Contact
Status Completed
Phase N/A
Start date June 2015
Completion date September 2015

See also
  Status Clinical Trial Phase
Active, not recruiting NCT06174961 - The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin Phase 4
Recruiting NCT04499274 - Ondansetron and Blood Coagulation N/A
Recruiting NCT04507711 - Palonosetron and Blood Coagulation N/A
Recruiting NCT06403163 - Transfusion Surveillance in Anaesthesia
Terminated NCT00288808 - Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements. Phase 1
Completed NCT03666650 - NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers Phase 4
Recruiting NCT04896203 - Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel Disease
Completed NCT03821597 - Sequential Compression Devices Effect on Fibrinolysis in Plastic Surgery Outpatients N/A
Completed NCT03168087 - Plasmalyte-148 Solution and Blood Coagulation
Not yet recruiting NCT05698160 - Biomarkers and Prediction of Tigecycline Induced Coagulation Dysfunction
Completed NCT02387944 - Bedside Evaluation of Coagulation in Children With Congenital Heart Disease N/A
Completed NCT03105180 - Irrigating Fluid and Blood Coagulation N/A
Recruiting NCT03255928 - Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)
Completed NCT03280368 - Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation
Completed NCT00493272 - Dilutional Coagulopathy in Patients Undergoing Elective Surgery Phase 1/Phase 2
Recruiting NCT02720679 - Investigation of the Genetics of Hematologic Diseases
Completed NCT03972839 - Comparison of Two D-Dimers Dosing Techniques
Completed NCT03734588 - Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors Phase 1/Phase 2
Completed NCT03876301 - Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants
Completed NCT00001927 - Study of Abnormal Blood Clotting in Children With Stroke N/A